1.

Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients

2.

Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients

3.

Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients

1.

Presence of Propionibacterium acnes in granulomas associates with a chronic disease course in Dutch sarcoidosis patients

1.

Activation of Downstream mTORC1 Target Ribosomal Protein S6 Kinase (S6K) Can Be Found in a Subgroup of Dutch Patients with Granulomatous Pulmonary Disease

2.

Activation of Downstream mTORC1 Target Ribosomal Protein S6 Kinase (S6K) Can Be Found in a Subgroup of Dutch Patients with Granulomatous Pulmonary Disease

3.

Activation of Downstream mTORC1 Target Ribosomal Protein S6 Kinase (S6K) Can Be Found in a Subgroup of Dutch Patients with Granulomatous Pulmonary Disease

1.

Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients

2.

Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients

3.

Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients